Termékek Árajánlat kéréshez szíveskedjen a kosárba tenni a kiválasztott terméket. Kosár tartalma Kat. szám Beszállító Termék megnevezése Kiszerelés MindSTEMEURO FI 2795-1005 A EURO "Epstein-Barr virus early antigen (EBV-EA)" "expressing cells"   FI 2795-1005 G EURO "Epstein-Barr virus early antigen (EBV-EA)" "expressing cells"   FI 2795-1005 X EURO "Epstein-Barr virus early antigen (EBV-EA)" "expressing cells"   FI 2795-1010 A EURO "Epstein-Barr virus early antigen (EBV-EA)" "expressing cells"   FI 2795-1010 G EURO "Epstein-Barr virus early antigen (EBV-EA)" "expressing cells"   FI 2799-1001-1 X EURO """BIOCHIP Sequence EBV"" fields A and B: EBV-CA (IgG) field C: EBV-CA (IgM) field D: EBV-EA field E: EBNA format 1001: per slide one patient format 1002: per slide two patients" " expressing cells expressing cells expressing cells expressing cells"   FI 2799-1001-21 X EURO """EUROPLUS BIOCHIP Sequence EBV"" field A: EBV-CA (IgG), gp125 ag, p19 ag field B: EBV-CA (IgG) field C: EBV-CA (IgM), gp125 ag, p19 ag field D: EBV-EA field E: EBNA format 1001: per slide " expr. cells, gp125/p19/ ag-free BIOCHIP expressing cells expressing cells expr. cells, gp12   FI 2799-1002-1 X EURO """BIOCHIP Sequence EBV"" fields A and B: EBV-CA (IgG) field C: EBV-CA (IgM) field D: EBV-EA field E: EBNA format 1001: per slide one patient format 1002: per slide two patients" " expressing cells expressing cells expressing cells expressing cells"   FI 2799-1002-21 X EURO """EUROPLUS BIOCHIP Sequence EBV"" field A: EBV-CA (IgG), gp125 ag, p19 ag field B: EBV-CA (IgG) field C: EBV-CA (IgM), gp125 ag, p19 ag field D: EBV-EA field E: EBNA format 1001: per slide " expr. cells, gp125/p19/ ag-free BIOCHIP expressing cells expressing cells expr. cells, gp12   FI 2799-2001-1 X EURO """BIOCHIP Sequence EBV"" fields A and B: EBV-CA (IgG) field C: EBV-CA (IgM) field D: EBV-EA field E: EBNA format 1001: per slide one patient format 1002: per slide two patients" " expressing cells expressing cells expressing cells expressing cells"   FI 2799-2001-21 X EURO """EUROPLUS BIOCHIP Sequence EBV"" field A: EBV-CA (IgG), gp125 ag, p19 ag field B: EBV-CA (IgG) field C: EBV-CA (IgM), gp125 ag, p19 ag field D: EBV-EA field E: EBNA format 1001: per slide " expr. cells, gp125/p19/ ag-free BIOCHIP expressing cells expressing cells expr. cells, gp12   FI 2799-2002-1 X EURO """BIOCHIP Sequence EBV"" fields A and B: EBV-CA (IgG) field C: EBV-CA (IgM) field D: EBV-EA field E: EBNA format 1001: per slide one patient format 1002: per slide two patients" " expressing cells expressing cells expressing cells expressing cells"   FI 2799-2002-21 X EURO """EUROPLUS BIOCHIP Sequence EBV"" field A: EBV-CA (IgG), gp125 ag, p19 ag field B: EBV-CA (IgG) field C: EBV-CA (IgM), gp125 ag, p19 ag field D: EBV-EA field E: EBNA format 1001: per slide " expr. cells, gp125/p19/ ag-free BIOCHIP expressing cells expressing cells expr. cells, gp12   FI 279a-1005-2 G EURO """Crimean Congo fever virus Mosaic 2"" CCHFV-GPC CCHFV-N" "3 BIOCHIPs per field: transfected cells transfected cells control transfection"   FI 279a-1005-2 M EURO """Crimean Congo fever virus Mosaic 2"" CCHFV-GPC CCHFV-N" "3 BIOCHIPs per field: transfected cells transfected cells control transfection"   FI 279a-1010-2 G EURO """Crimean Congo fever virus Mosaic 2"" CCHFV-GPC CCHFV-N" "3 BIOCHIPs per field: transfected cells transfected cells control transfection"   FI 279a-1010-2 M EURO """Crimean Congo fever virus Mosaic 2"" CCHFV-GPC CCHFV-N" "3 BIOCHIPs per field: transfected cells transfected cells control transfection"   FI 279a-2010-2 G EURO """Crimean Congo fever virus Mosaic 2"" CCHFV-GPC CCHFV-N" "3 BIOCHIPs per field: transfected cells transfected cells control transfection"   FI 279a-2010-2 M EURO """Crimean Congo fever virus Mosaic 2"" CCHFV-GPC CCHFV-N" "3 BIOCHIPs per field: transfected cells transfected cells control transfection"   FI 280a-1005 G EURO Rift Valley fever virus (RVFV) "infected and non- infected cells (2 BIOCHIPs per field)"   FI 280a-1005 M EURO Rift Valley fever virus (RVFV) "infected and non- infected cells (2 BIOCHIPs per field)"   FI 280a-1010 G EURO Rift Valley fever virus (RVFV) "infected and non- infected cells (2 BIOCHIPs per field)"   FI 280a-1010 M EURO Rift Valley fever virus (RVFV) "infected and non- infected cells (2 BIOCHIPs per field)"   FI 2821-1001-1 G EURO """Respiratory Tract Profile 1"" (consisting of 21 different substrates)" ####################################################################################################   FI 2821-1001-1 M EURO """Respiratory Tract Profile 1"" (consisting of 21 different substrates)" ####################################################################################################   FI 2821-1002-1 G EURO """Respiratory Tract Profile 1"" (consisting of 21 different substrates)" ####################################################################################################   FI 2821-1002-1 M EURO """Respiratory Tract Profile 1"" (consisting of 21 different substrates)" ####################################################################################################   FI 2821-2002-1 G EURO """Respiratory Tract Profile 1"" (consisting of 21 different substrates)" ####################################################################################################   FI 2821-2002-1 M EURO """Respiratory Tract Profile 1"" (consisting of 21 different substrates)" ####################################################################################################   FI 2822-1001-1 G EURO """Exanthema Profile 1"" (consisting of 21 different substrates)" ####################################################################################################   FI 2822-1001-1 M * EURO """Exanthema Profile 1"" (consisting of 21 different substrates)" ####################################################################################################   FI 2822-1002-1 G EURO """Exanthema Profile 1"" (consisting of 21 different substrates)" ####################################################################################################   FI 2822-1002-1 M * EURO """Exanthema Profile 1"" (consisting of 21 different substrates)" ####################################################################################################   FI 2823-1001-1 G * EURO """Lymphadenitis Profile 1"" (consisting of 21 different substrates)" ####################################################################################################   FI 2823-1001-1 M * EURO """Lymphadenitis Profile 1"" (consisting of 21 different substrates)" ####################################################################################################   FI 2823-1002-1 G * EURO """Lymphadenitis Profile 1"" (consisting of 21 different substrates)" ####################################################################################################   FI 2823-1002-1 M * EURO """Lymphadenitis Profile 1"" (consisting of 21 different substrates)" ####################################################################################################   FI 2824-1001-1 G EURO """Central Nervous System Profile 1"" (consisting of 21 different substrates)" ####################################################################################################   FI 2824-1001-1 M * EURO """Central Nervous System Profile 1"" (consisting of 21 different substrates)" ####################################################################################################   FI 2824-1002-1 G EURO """Central Nervous System Profile 1"" (consisting of 21 different substrates)" ####################################################################################################   FI 2824-1002-1 M * EURO """Central Nervous System Profile 1"" (consisting of 21 different substrates)" ####################################################################################################   FI 2825-1001-1 G EURO """Myocarditis Profile 1"" (consisting of 17 different substrates)" ####################################################################################################   FI 2825-1001-1 M EURO """Myocarditis Profile 1"" (consisting of 17 different substrates)" ####################################################################################################   FI 2825-1002-1 G EURO """Myocarditis Profile 1"" (consisting of 17 different substrates)" ####################################################################################################   FI 2825-1002-1 M EURO """Myocarditis Profile 1"" (consisting of 17 different substrates)" ####################################################################################################   FI 2826-1001-1 G EURO """Infectious Arthritis Profile 1"" (consisting of 13 different substrates)" "field A: verification BIOCHIP, VZV, Influenza virus type A (H1N1 and H3N2) and B field B: Yersin   FI 2826-1001-1 M EURO """Infectious Arthritis Profile 1"" (consisting of 13 different substrates)" "field A: verification BIOCHIP, VZV, Influenza virus type A (H1N1 and H3N2) and B field B: Yersin   FI 2826-1002-1 G EURO """Infectious Arthritis Profile 1"" (consisting of 13 different substrates)" "field A: verification BIOCHIP, VZV, Influenza virus type A (H1N1 and H3N2) and B field B: Yersin   FI 2826-1002-1 M EURO """Infectious Arthritis Profile 1"" (consisting of 13 different substrates)" "field A: verification BIOCHIP, VZV, Influenza virus type A (H1N1 and H3N2) and B field B: Yersin   FI 2861-1003 A EURO "Candida albicans" "fungal smear"   [101]   [102]   [103]   [104]   [105]   [106]   [107]   [108]   [109]   [110]   [111]   [112]   [113]   [114]   [115]   [116]   [117]   [118]   [119]   [120]     © 2024 - Immunotrin Kft. Használati útmutatók   |   Adatvédelmi tájékoztató info@immunotrin.hu